- Physical editions of Nintendo Switch games are unavailable, sparking speculation about a re-release strategy for the rumored Switch 2.
- Out-of-stock titles like 'Paper Mario: The Origami King' raise collector concerns over possible re-releases with changed branding.
- Live Sunday: Matt Maley’s Volatility Trading Plan for Earnings, Tariffs, & the Fed [Secure Your Seat Here]
Physical editions of popular Nintendo ADR's NTDOY Nintendo Switch games are currently unavailable at various retailers, prompting speculation about a potential re-release strategy ahead of the launch of the rumored Switch 2.
According to Kotaku, Nintendeal, a Twitter account focused on Nintendo deals, identified out-of-stock titles like "Paper Mario: The Origami King" and "Metroid Dread."
Moreover, Discord user AShadowLink compiled a list of affected games, including "Super Mario Odyssey," "Fire Emblem: Engage," and more, noting their absence from major retailers such as Amazon.com Inc AMZN, Walmart Inc WMT, Target Corp TGT, and GameStop Corp GME.
Speculation arose that Nintendo might be planning a re-release similar to the "Greatest Hits" or "Nintendo Selects" campaigns for previous consoles. These re-releases typically feature new Stock Keeping Units (SKUs), possibly indicating compatibility with both the current Switch and its anticipated successor.
It's worth noting that these re-releases may feature distinctive branding, potentially affecting the cover art. Users on platforms like ResetEra and Nintendeal caution against panic buying, suggesting that Nintendo's move could be a strategic re-release rather than a scarcity scheme.
While the situation doesn't necessarily indicate immediate game discontinuation, collectors may want to keep an eye out for original copies before potential re-releases with altered branding hit the shelves.
Read Next: Nintendo Commits To Support Switch With New Titles Until 2025 As New Console Looms
Photo by Lucas Santos on Unsplash.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.